| MR |
Enshi (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
22 Oktober 2024 |
| MSL Manager - Hematology |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
14 Mei 2024 |
| MSL Tumeurs Solides - Nord Est |
Field Non-Sales (France) |
France |
International |
Innovative Medicines |
Research & Development |
29 April 2024 |
| Oncology MSL |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
18 Oktober 2024 |
| Order Management Specialist - Temporary |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
25 September 2024 |
| Order to Cash Radioligand Therapy Sr. Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
06 Augustus 2024 |
| P&O Manager,People Partner |
Shanghai (Shanghai) |
China |
People & Organization |
Innovative Medicines |
Human Resources |
03 September 2024 |
| P2P Process Excellence |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
02 Oktober 2024 |
| P2P Service Delivery (SD) Lead NGSC |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
07 Oktober 2024 |
| Patient Journey Partner Lead GTx |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Research & Development |
21 Oktober 2024 |
| Patient Safety Manager |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
Development |
Innovative Medicines |
Research & Development |
04 September 2024 |
| Procure to Pay Business Partner Management |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
16 Oktober 2024 |
| Procure to Pay Business Partner US Temporary |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
22 Oktober 2024 |
| Procure to Pay Senior Specialist MR11 |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
23 Juli 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 Juli 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 Augustus 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 Juli 2024 |
| Product Specialist |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
30 Juli 2024 |
| Product Specialist |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
05 Augustus 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 Augustus 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 Juli 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 Augustus 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 Juli 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 Augustus 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 Juli 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 Augustus 2024 |
| Product Specialist |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
23 Juli 2024 |
| Product Specialist |
Jingzhou (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
06 Augustus 2024 |
| QA Specialist APQR |
INSURGENTES |
Mexico |
Operations |
Innovative Medicines |
Quality |
03 September 2024 |
| Quality Assurance Specialist |
Murcia |
Spain |
Operations |
Innovative Medicines |
Quality |
16 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Control Staff |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
18 Oktober 2024 |
| Quality Operations Specialist - Batch Release |
INSURGENTES |
Mexico |
Operations |
Innovative Medicines |
Quality |
07 Oktober 2024 |
| R2R Accountant |
Moscow (City) |
Russian Fed. |
Finance |
CTS |
Audit & Finance |
22 Oktober 2024 |
| RA Manager |
INSURGENTES |
Mexico |
Development |
Innovative Medicines |
Research & Development |
03 September 2024 |
| Recent Bachelor or Master Graduate |
Basel (City) |
Switzerland |
Biomedical Research |
Pharma Research |
Others |
22 Oktober 2024 |
| Record to Report Specialist |
INSURGENTES |
Mexico |
Finance |
CTS |
Audit & Finance |
05 September 2024 |
| Record to Report Sr Specialist |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Record to Report Sr Specialist Intercompany |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Record to Report Sr Specialist US |
INSURGENTES |
Mexico |
Operations |
CTS |
Audit & Finance |
10 September 2024 |
| Regulatory Affairs Manager |
Beijing (Beijing) |
China |
Development |
Innovative Medicines |
Research & Development |
01 September 2024 |
| Responsable Relations Sociales H/F |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
People & Organization |
Innovative Medicines |
Human Resources |
24 September 2024 |
| Revenue Accounting Manager |
Shanghai (Shanghai) |
China |
Finance |
CTS |
Audit & Finance |
17 Juli 2024 |
| RWE Lead H/F CDD 12 mois |
Paris Headquarter (Novartis Pharma S.A.S.) |
France |
International |
Innovative Medicines |
Research & Development |
04 Oktober 2024 |
| SALES |
Nanjing (Jiangsu Province) |
China |
International |
Innovative Medicines |
Sales |
15 Oktober 2024 |
| Sales Value Associate CDMX (Virtual) |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Sales |
13 September 2024 |